Quantcast

Capitalizing on Opportunities in Cord Blood Industry Growth (2013 Version)

August 14, 2013

MarketResearch.com announces the addition of a new market research report in Biotechnology to their product offering: Capitalizing on Opportunities in Cord Blood Industry Growth (2013 Version). http://www.marketresearch.com/land/product.asp?productid=7470708&progid=85706

Rockville, MD (PRWEB) August 14, 2013

Capitalizing on Opportunities in Cord Blood Industry Growth (2013 Version)

The cord blood banking industry is one of the fastest growing industries in the world. There were only 23 active cord blood banks as of 2005, and now there are 485 worldwide. Cord blood banks now exist in nearly every developed country, as well as within most developing nations. That is a 21-fold increase (2,100%) in the companies involved in the industry, over only a seven year period. This rapid market growth represents both an opportunity to profit, as well as swarming competition.

This industry report reveals strategies for dominating the global cord blood banking industry, including tactics for global expansion, patterns in regional dominance, and methods for investing in the sector. A distinctive feature of this report is a global survey of expectant parents who reveal their deepest fears, core expectations, and critical factors influencing buying decisions.

Over the past 12 months, the cord blood banking industry has expanded through double digit growth, due to new entrants in the cord blood banking industry, as well as revenue growth at existing operations. To guide industry competitors, this report carefully considers the following questions:

-What factors are causing a substantial number of new cord blood banks to open up business?

-What will be the effect of these new entrants to the cord blood banking industry?

-How can existing competitors maintain a position of dominance among this trend?

Deeper analysis also reveals that existing cord blood banks follow a bi-modal distribution, either experiencing flat-line growth (less than 3% per annum) or substantively building revenue (25% or more per annum).

The report also reveals strategies for dominating the global cord blood banking industry, including tactics for global expansion, patterns in regional dominance, and methods for investing in the sector. A distinctive feature is a global survey of expectant parents who reveal their deepest fears, core expectations, and critical factors influencing buying decisions. It is designed to guide the decision-making of cord blood banks worldwide, as well as to advise private, corporate, and institutional investors entering into the global cord blood banking market.

To order this report:

Capitalizing on Opportunities in Cord Blood Industry Growth (2013 Version)

Contact: Shauna

800.298.5699

Customerservice(at)marketresearch(dot)com

About BioInformant Worldwide, L.L.C.

BioInformant is the global leader in stem cell industry data. As a specialty research company, we use technology to track and identify profit opportunities in stem cell markets and provide this data to clients that require stem cell strategies. We advise companies on how to market stem cell products for immediate profit, competitively position products for additional profits within 1-3 months, and approach product development for dramatic long-term profits. Our clients acquire more stem cell customers within 30 days, using the strategies in our reports.

About MarketResearch.com

MarketResearch.com is the leading provider of global market intelligence products and services. With research reports from more than 720 top consulting and advisory firms, MarketResearch.com offers instant online access to the world’s most extensive database of expert insights on global industries, companies, products, and trends. Moreover, MarketResearch.com’s Research Specialists have in-depth knowledge of the publishers and the various types of reports in their respective industries and are ready to provide research assistance. For more information, call Cindy Frei at 240.747.3014 or visit http://www.marketresearch.com

Follow us on Facebook http://www.facebook.com/marketresearchdotcom

Follow us on Twitter http://www.twitter.com/marketresearch_

Capitalizing on Opportunities in Cord Blood Industry Growth (2013 Version) – Table of Contents:

PART 1: Cord Blood Banking Industry – Market Overview & Outlook

I. History of Cord Blood Banking

II. Likelihood of Needing a Stem Cell Transplant

III. Current, Future, and Projected Conditions Treatable with Cord Blood Transplant

IV. Cord Blood vs. Bone Marrow and Peripheral Blood, as a Source of Hematopoietic Stem Cells for Transplant

V. Cord Blood Banking – Storage Options

PART 2: Expansion and Growth – Trailing 12-Month Analysis & Future Projections

I. Fast-Growth vs. Flat-Growth – Bimodal Distribution

II. Growth Rate

III. Revenue

IV. Industry Conditions

V. Trends

A. Rates of Worldwide Cord Blood Storage (Units per Year)

B. Medical Society Opinions of Cord Blood Banking

C. Cord Blood Scientific Publication Rates

D. Cord Blood Research Funding Levels (Grant Analysis)

1. U.S. Grant Funding Analysis

2. Worldwide Grant Funding Analysis

E. Cord Blood Patent Breakdown

F. Rates of Cord Blood Research Product Development

G. Top Countries for Cord Blood Research

H. Cord Blood Conferences & Events

VI. Cord Tissue Storage

VII. Barriers to Entering the Cord Blood Market

VIII. Leveraging Novel Tactics for Substantive Revenue Growth

IX. Comparing to the Competition – Setting Yourself Apart

PART 3: Parent Survey – Continuing to Grow by Listening to Expectant Parents

I. Global Expectant Parent Survey (2013)

II. Summary of Conclusions

APPENDICES

APPENDIX A – Existing Conditions Treatable with Cord Blood Transplant

APPENDIX B – U.S. List of Cord Blood Banks, by Type of Bank (Private, Hybrid, or Public)

APPENDIX C – Global List of Cord Blood Banks, 2013

APPENDIX D – Accreditation Standards by U.S Cord Blood Bank, Public and Private

APPENDIX E – AABB Accredited Cord Blood Banks Worldwide, 2013

APPENDIX F – Cord Blood Stem Cell Legislation by U.S. State

APPENDIX G – Case Study: Virgin Health Bank

For the original version on PRWeb visit: http://www.prweb.com/releases/2013/8/prweb11019696.htm


Source: prweb



comments powered by Disqus